African Congress for Clinical Trials
Lambaréné, 10-14 November 2019 (2nd edition)
Clinical trial in Sub-saharan Africa : Challenge or Opportunity ?
Long-term strategies in medical research and public health for control of emerging and re-emerging infectious diseases.
Acronym : SECC
The SECC project is a grant won by CERMEL in 2015 after a call for applications was put out jointly by WHO/TDR and EDCTP, when the Ebola epidemic occurred in West Africa. The call aimed to develop and/or reinforce capacities and research in Sub-Saharan Africa to control Ebola virus related diseases.
- To implement capacity building for clinical research in Sub-Saharan Africa through CERMEL, which can form the reference for, or support or partner to other research centers.
- To create a place where people from research, public health and society can exchange views.
- To develop long-term actions that will persist beyond the timeframe and the funding of the project.
- To develop and reinforce the analytical capabilities and the biosafety level of CERMEL laboratories.
- To promote clinical trials partnerships and support all partners.
- To develop a decision aids framework for Ebola virus related diseases.